Your browser doesn't support javascript.
loading
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights.
Lenz, Christian; Slack, Mary P E; Shea, Kimberly M; Reinert, Ralf René; Taysi, Bülent N; Swerdlow, David L.
Afiliação
  • Lenz C; Pfizer Vaccines, Pfizer Inc, Berlin, Germany.
  • Slack MPE; Griffith University, School of Medicine and Dentistry, Griffith University Gold Coast campus, Queensland, Australia.
  • Shea KM; Pfizer Vaccines, Pfizer Inc, Cambridge, MA, USA.
  • Reinert RR; Pfizer Vaccines, Pfizer Inc, Berlin, Germany.
  • Taysi BN; Pfizer Vaccines, Pfizer Inc, Istanbul, Turkey.
  • Swerdlow DL; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA.
Crit Rev Microbiol ; : 1-14, 2023 Apr 19.
Article em En | MEDLINE | ID: mdl-37074754
ABSTRACT
Although SARS-CoV-2, responsible for COVID-19, is primarily a respiratory infection, a broad spectrum of cardiac, pulmonary, neurologic, and metabolic complications can occur. More than 50 long-term symptoms of COVID-19 have been described, and as many as 80% of patients may develop ≥1 long-term symptom. To summarize current perspectives of long-term sequelae of COVID-19, we conducted a PubMed search describing the long-term cardiovascular, pulmonary, gastrointestinal, and neurologic effects post-SARS-CoV-2 infection and mechanistic insights and risk factors for the above-mentioned sequelae. Emerging risk factors of long-term sequelae include older age (≥65 years), female sex, Black or Asian race, Hispanic ethnicity, and presence of comorbidities. There is an urgent need to better understand ongoing effects of COVID-19. Prospective studies evaluating long-term effects of COVID-19 in all body systems and patient groups will facilitate appropriate management and assess burden of care. Clinicians should ensure patients are followed up and managed appropriately, especially those in at-risk groups. Healthcare systems worldwide need to develop approaches to follow-up and support patients recovering from COVID-19. Surveillance programs can enhance prevention and treatment efforts for those most vulnerable.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Crit Rev Microbiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Crit Rev Microbiol Ano de publicação: 2023 Tipo de documento: Article